Oocyte quality is one of the major factors affecting success in in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) applications. Several studies have shown that the morphological studies are insufficient to determine the oocyte quality (1,2). Therefore, some researchers have addressed biochemical markers to predict the oocyte quality, secretion of cumulus corona, and granulosa cells surrounding the oocyte in the developmental stages of the follicle (3-5).
Introduction
Throughout the history of the world, the ones who had confronted the bitterest face of poverty and war had always been the women. As known poverty and war affects human health either directly or indirectly, the effects of this condition on health and status of women in the society should not be ignored. This study intends to cast light on the effects of war and poverty on the reproductive health of women. For this purpose, the face of war affecting the women, the problem of immigration, inequalities in distribution of income based on gender and the effects of all these on the reproductive health of women will be addressed.
War and Women's Health
Famine, synonymous with war and poverty, is clearer for women; war means deep disadvantages such as full destruction, loss of future and uncertainty for women. Wars are conflicts that destroy families, societies and cultures that negatively affect the health of community and cause violation of human rights. According to the data of World Health Organization (WHO) and World Bank, in 2002 wars had been among the first ten reasons which killed the most and caused disabilities. Civil losses are at the rate of 90% within all losses (1). War has many negative effects on human health. One of these is its effect of shortening the average human life. According to the data of WHO, the average human life is 68.1 years for males and 72.7 years for females. It is being thought that severe military conflicts in Africa shorten the expected lifetime for more than 2 years. In general, WHO had calculated that 269 thousand people had died in 1999 due to the effect of wars and that loss of 8.44 million healthy years of life had occurred (2, 3) . Wars negatively affect the provision of health services. Health institutions such as hospitals, laboratories and health centers are direct targets of war. Moreover, the wars cause the migration of qualified health employees, and thus the health services hitches. Assessments made indicate that the effect of destruction in the infrastructure of health continues for 5-10 years even after the finalization of conflicts (3) . Due to resource requirements in the restructuring investments after war, the share allocated to health has decreased (1).
Mortalities and Morbidities
The ones who are most affected from wars are women and children. While deaths depending on direct violence affect the male population, the indirect deaths kill children, women and elders more. In Iraq between 1990-1994, infant deaths had shown this reality in its more bare form with an increase of 600% (4). The war taking five years increases the child deaths under age of 5 by 13%. Also 47% of all the refugees in the world and 50% of asylum seekers and displaced people are women and girls and 44% refugees and asylum seekers are children under the age of 18 (5) . As the result of wars and armed conflicts, women are
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For fertilization, metaphase II (MII) oocytes were taken into consideration for statistical analysis and the developing embryos were investigated in terms of blastomere number (According to Baczkowski et al's criteria), the percentage of fragmentation, and their size (whether they were of equal size) (20) .
Semen Analysis and Preparation of Sperm Sperm analysis was carried out as per the World Health Organization (WHO) criteria (21) .
ICSI Procedure
The sperm prepared by using the Narishige micromanipulator was injected into the oocytes MII stage. To check for fertilization of oocytes (eggs), the fertilized oocytes were observed 16-20 hours after ICSI for the presence of two round nuclear structures, the male and female pronuclei (PN), formed by the sperm and egg.
Assessment of the Embryo
The morphology of the embryo was assessed using Alpha, ESHRE, ASRM consensus measures.
Statistical Analysis Statistical analysis was performed using SPSS version 22.0 software (IBM Corporation, Armonk, NY, USA). Descriptive data were expressed in mean, standard deviation, and frequency. The Shapiro-Wilks test was used to analyze normally distributed variables. Moreover, Mann Whitney U test was used for the comparison of quantitative data and the comparisons between 2 groups who do not have normally distributed parameters. Oneway Analysis of Variance (ANOVA) test was used for the comparisons between groups with normally distributed parameters and differences between groups were examined by Tamhane T2 test. Furthermore, Kruskal-Wallis test was used for the comparisons between the groups whose parameters were not normally distributed and Mann Whitney U test was used for detection of the group causing difference. In addition, chi-square test, continuity (Yates) correction test, and Fisher exact test were used for the comparison of qualitative data. Significance was assessed at P <0.05 level.
Results
No statistically significant difference was observed among AMH groups in terms of fertilization percentages (P > 0.05). The rate of pregnancy was found to be lower in the group with very low level of AMH (14.3%) than the groups with moderate level of AMH (53.8%) (P = 0.022) and high level of AMH (54.5%) (P = 0.035) (P < 0.05). There was also no significant difference among other groups (P > 0.05).
However, there was a statistically significant correlation (P = 0.001, P < 0.01, P = 0.044, P < 0.05) in the positive direction and at the levels of 51.5% and 32.1% between the oocyte counts and AMH levels of women aged under and 35 years and over (Figures 1 and 2 ). There was no statistically significant difference in pregnancy rate among the group of women who were under and over 35 years of age (P > 0.05) as per the induction of drug dose protocol.
In patients who were under 35 years of age, the area under the ROC curve for the AMH level was 0.771 and the standard error was 0.082, which was significantly higher than 0.5 (P = 0.006, P < 0.05). In patients who were over 35 years of age, the area under the ROC curve for AMH level was found to be 0.558 and the standard error was 0.124, which was not significantly higher than 0.5 (P = 0.670, P > 0.05). For the AMH test, the cut-off point in pregnant women under 35 years of age was 1.72. Of this value, the sensitivity, the specificity, and the positive Figure 3 ). The cut-off point for the patients who were over 35 years of age could not be determined, since the area under ROC curve for AMH was not significantly higher than 0.5.
Discussion
The results of our study were similar to the positive correlation between FF (AMH) level and the quality of oocyte and embryo as shown in the study by Kim et al (22) . In the study by Irez et al in 2011, the relationship between FF (AMH) level and the quality of oocyte and embryo was reported (23) . In the studies conducted by Ebner et al (24), Irez et al (23) , and Kim et al (22) in the years of 2006, 2011, and 2014, they found that FF (AMH) levels were directly correlated with oocyte quality. This piece of finding was in line with the previous studies on AMH.
The FF (AMH) and oocyte fertilization success were evaluated as a very good predictor of IVF application in the retrospective study by Takahashi et al (25) . In this study, it was understood that FF (AMH) level did not show a significant relationship with ICSI fertilization.
Investigators showed that FF (AMH) levels were useful markers for embryo implantation; however, they could not find a significant difference in follicles producing high and low AMH in terms of oocyte and embryo quality (10) . On the other hand, Cupisti et al (3) and Mehta et al (26) demonstrated an inverse relation of FF (AMH) level with potential fertilization in oocyte maturation and growth, oocyte quality, and pregnancy rate. In the present study, the AMH levels were measured in all of the follicles with a diameter ≥15 mm, rather than specific follicle. Through measurements, we observed that the specific follicles which contained oocytes were not affected by the other follicular micro environment.
In this study clinical pregnancy rates were found to be (statistically) significantly high when the FF (AMH) levels were higher than 2.1 ng/mL (Table 4 ). The FF (AMH) levels were found to have a predictive effect on pregnancy in women under 35 years of age, compared to the women over 35 years of age. Nonetheless, this study suffers from some limitations. First, only the FF samples taken from the follicles ≥15 mm were included in the study, and the MII oocytes obtained from these follicles were fertilized by ICSI. However, the sperm samples obtained via TESA or micro-TESE in the patients with the diagnosis of azoospermia and patients with polycystic ovary syndrome were excluded, which in turn limited the sample size of this study. Second, due to the high cost, we were unable to carry out molecular analyses. Third, only women within the age range of 21 to 42 years were included in this study, as the number of oocytes is reduced with increasing age.
In conclusion, the results of this study showed that the FF (AMH) levels were associated with oocyte and embryo quality and FF (AMH) levels were the predictors of clinical pregnancy in patients less than 35 years of age. However, further large-scale studies using molecular testing are needed to confirm these findings.
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